Semaglutide vs. Tirzepatide: Which Is Right for You?

Semaglutide and tirzepatide are both prescription medications used for weight management, but they differ in how they work: semaglutide acts on the GLP-1 pathway, while tirzepatide acts on two pathways, GIP and GLP-1. Neither is universally better, and which one is right for you is a medical decision made at consultation.

How do they differ?

The core difference is the hormone systems each medication engages. Both reduce appetite and food preoccupation for many patients, but they do so through different mechanisms:

• •Semaglutide is a GLP-1 receptor agonist, mimicking a single gut hormone that signals fullness
• •Tirzepatide is a dual agonist, acting on both GIP and GLP-1 receptors
• •Both slow gastric emptying and influence appetite signaling in the brain
• •Both are prescription treatments requiring evaluation and physician supervision

How does a physician choose?

There is no one-size answer. At Captivate Medical Wellness in Manhattan's Flatiron District, Dr. Marcelo Taborga, MD, a board-certified internist, weighs your medical history, other conditions, how your body tolerates treatment, and your goals before recommending either option. Internal-medicine training means he looks at the whole picture, not a single metric, and explains his reasoning in English or Spanish. The aim is the right fit for you, not the trendiest name.

Why individualization matters

Two patients with similar goals may do better on different medications, or may need a different plan entirely. Tolerance to side effects such as nausea that may occur, existing health conditions, and how you respond over time all factor in. Because these are prescription medications that are not appropriate for everyone, eligibility and contraindications are assessed at consultation, and the plan is adjusted responsibly as your body responds. Results vary, and no specific outcome can be promised.

A medical decision, not a retail one

Choosing between semaglutide and tirzepatide is not something to settle based on online reviews or a friend's experience. It is a clinical judgment that depends on your physiology and history. What worked well for someone else may not suit you at all, and what suits you may not be obvious from the outside. That is the value of a physician-led program in New York City, where a doctor, not an algorithm, makes the call with you and can change course if your response calls for it.

Convenient to your neighborhood

The practice is in the Flatiron District of Manhattan, in New York County, close to Union Square, NoMad, and Gramercy and easy to reach by the 23rd Street and Union Square subway lines. That accessibility supports the regular follow-up that lets a physician fine-tune your choice over time, rather than setting it once and walking away.

What changing course looks like

A real advantage of supervised care is that the first choice is not the last word. If your response or tolerance suggests a different path, a physician can adjust the plan responsibly rather than leaving you stuck. That flexibility is only possible with ongoing monitoring and a doctor who knows your history. It is one more reason the decision between these medications belongs in a clinical relationship, not a one-time online order.

Talk it through with a physician

The best way to decide between semaglutide and tirzepatide is a consultation where a physician reviews your specifics. Call Captivate Medical Wellness in the Flatiron District at (332) 237-3661 to schedule your visit with Dr. Taborga and find the option that fits you.